Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,376
Closed -$1.23M 2048
2023
Q4
$1.23M Buy
12,376
+10,220
+474% +$1.06M 0.01% 743
2023
Q3
$227K Buy
2,156
+119
+6% +$13.3K ﹤0.01% 1489
2023
Q2
$247K Sell
2,037
-2,155
-51% -$236K ﹤0.01% 1621
2023
Q1
$458K Buy
+4,192
New +$443K ﹤0.01% 1361
2022
Q3
Sell
-5,905
Closed -$652K 2375
2022
Q2
$652K Buy
+5,905
New +$678K 0.01% 1264
2021
Q2
Sell
-15,454
Closed -$2.06M 2893
2021
Q1
$2.06M Buy
15,454
+11,211
+264% +$1.47M 0.03% 564
2020
Q4
$483K Sell
4,243
-6,109
-59% -$630K ﹤0.01% 1277
2020
Q3
$951K Buy
10,352
+5,842
+130% +$560K 0.02% 705
2020
Q2
$388K Buy
+4,510
New +$350K 0.01% 1193
2019
Q4
Sell
-7,600
Closed -$756K 1956
2019
Q3
$756K Buy
7,600
+5,300
+230% +$584K 0.03% 483
2019
Q2
$279K Buy
+2,300
New +$247K 0.01% 739

Other funds holding JBTM

Michael Gelband's JBTM Position: Q1 2024 in Review

Michael Gelband sold out of JBT Marel (JBTM) in Q1 2024, closing a stake of 12,376 shares — an estimated $1.23M sold.

Michael Gelband first reported a position in JBTM in Q2 2019 and held it in 11 quarters. The position peaked at $2.06M in Q1 2021. 288 funds tracked by Wall St. Rank hold JBTM as of Q1 2024.

  • Michael Gelband reported no remaining JBT Marel position as of Q1 2024 after selling out during the quarter.
  • Michael Gelband sold 12,376 JBT Marel shares in Q1 2024, an estimated $1.23M.
  • Michael Gelband first reported a position in JBT Marel in Q2 2019 and held it in 11 quarters.
  • Michael Gelband's JBT Marel position peaked at $2.06M in Q1 2021.
  • 288 funds tracked by Wall St. Rank held JBT Marel as of Q1 2024.

Based on ExodusPoint Capital Management's 13F filing for Q1 2024, filed 14 May 2024.